subject: UMLS:C3641728


subject: UMLS:C3641728

object_name: B-cell lymphoma recurrent

tested_intervention: unsure


subject: UMLS:C3641728

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C3641728

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C3641728

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Mantle cell lymphoma refractory


subject: UNII:4F4X42SYQ6

object_name: Mantle cell lymphoma recurrent


subject: UNII:4F4X42SYQ6

object_name: Marginal zone lymphoma refractory


subject: UNII:4F4X42SYQ6

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:4F4X42SYQ6

object_name: B-cell lymphoma refractory


subject: UNII:4F4X42SYQ6

object_name: Refractory Grade 1 Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Refractory Grade 2 Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Refractory Grade 3a Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:4F4X42SYQ6

object_name: Marginal zone lymphoma recurrent


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: dental caries


subject: UNII:R8DG7T2D3A

object_name: Dental Caries, CTCAE


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:16240

subject_name: Hioxyl


subject: CHEBI:16240


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Critical Illness


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C5446291

subject_name: Letetresgene autoleucel

object_name: neoplasm

tested_intervention: yes


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:9570

subject_name: Thiotepa


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan


subject: UMLS:C1134640

subject_name: Recombinant Fowlpox-Prostate Specific Antigen Vaccine

object_name: hormone-resistant prostate carcinoma


subject: UMLS:C1134640

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C1134640

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C1134640

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C1134640

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C1134640

object_name: Prostate cancer recurrent


subject: UMLS:C1134640

object_name: prostate adenocarcinoma


subject: UNII:59WJ3TGA5K

subject_name: RILIMOGENE GALVACIREPVEC


subject: UNII:59WJ3TGA5K


subject: UNII:59WJ3TGA5K


subject: UNII:59WJ3TGA5K


subject: UNII:59WJ3TGA5K


subject: UNII:59WJ3TGA5K


subject: UNII:59WJ3TGA5K


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Silent myocardial ischemia


subject: CHEBI:87681

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:70105374

object_name: obesity


subject: PUBCHEM.COMPOUND:70105374

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:70105374

object_name: inherited lipid metabolism disorder


subject: PUBCHEM.COMPOUND:70105374

object_name: Dyslipidemia


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:32020


subject: UNII:QX45B99R3J

subject_name: Mavacamten

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:291342

subject_name: Desloratadine

object_name: Atopic rhinitis


subject: CHEBI:291342

object_name: Hay fever


subject: PUBCHEM.COMPOUND:4490623

object_name: neuralgia


subject: PUBCHEM.COMPOUND:4490623

object_name: Neuropathic pain


subject: PUBCHEM.COMPOUND:4490623

object_name: peripheral nervous system disorder


subject: PUBCHEM.COMPOUND:4490623

object_name: neuropathy


subject: CHEBI:9506

subject_name: tetrodotoxin


subject: CHEBI:9506


subject: CHEBI:9506


subject: CHEBI:9506


subject: CHEBI:180459


subject: CHEBI:180459


subject: CHEBI:180459


subject: CHEBI:180459


subject: CHEBI:135883

subject_name: Canfosfamide

object_name: non-small cell lung carcinoma


subject: UMLS:C1258106

subject_name: TLK 286


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: end stage renal failure


subject: CHEBI:81579

object_name: Chronic uremia


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: CHEBI:7986


subject: UMLS:C1709066

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: opioid abuse


subject: CHEBI:63631

subject_name: Topiramate

object_name: Restless legs


subject: CHEBI:132774

subject_name: Roxadustat


subject: CHEBI:132774


subject: UMLS:C3713379


subject: UMLS:C3713379


subject: UNII:WE665JB15R

subject_name: POMAGLUMETAD METHIONIL

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:74405857

subject_name: Pomaglumetad methionil


subject: UMLS:C4705040

subject_name: pomaglumetad methionil


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor

object_name: IgA Nephropathy


subject: UMLS:C0003015


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: AL amyloidosis


subject: CHEBI:63791

object_name: primary systemic amyloidosis


subject: PUBCHEM.COMPOUND:496847

subject_name: vamorolone

object_name: Duchenne muscular dystrophy


subject: CHEBI:11909

subject_name: Sepranolone

object_name: fragile X-associated tremor/ataxia syndrome


subject: CHEBI:50169

subject_name: Brexanolone


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: cystic fibrosis


subject: UMLS:C5827068

object_name: recessive dystrophic epidermolysis bullosa


subject: UMLS:C0879272

object_name: B-cell neoplasm


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: benign prostatic hyperplasia


subject: UNII:1W5N8SZD9A

subject_name: Glufosfamide

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:1W5N8SZD9A

object_name: Adult Soft Tissue Sarcoma


subject: UNII:1W5N8SZD9A

object_name: sarcoma


subject: UNII:1W5N8SZD9A

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:1W5N8SZD9A

object_name: soft tissue sarcoma


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:47097

object_name: Recurrent Glioblastoma


subject: CHEBI:47097

object_name: Recurrent Childhood Gliosarcoma


subject: CHEBI:47097

object_name: Recurrent Gliosarcoma


subject: CHEBI:47097

object_name: supratentorial cancer


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: PUBCHEM.COMPOUND:132371114

subject_name: Hydroxynorketamine hydrochloride

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:132371114

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:122707132

subject_name: Talwin Nx

object_name: bipolar disorder


subject: MESH:C050228

subject_name: talwin Nx


subject: PUBCHEM.COMPOUND:137355584

subject_name: Mufemilast

object_name: psoriasis


subject: MESH:C000720495

subject_name: GLS-5310 vaccine


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: glaucoma


subject: CHEBI:51230

object_name: Glaucoma, CTCAE


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies

object_name: pregnancy related


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: CHEBI:51799

subject_name: Imipenem

object_name: Complicated intra-abdominal infection


subject: CHEBI:51799

object_name: Complicated urinary tract infection


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:91950


subject: CHEBI:91950


subject: CHEBI:3697

subject_name: Cilastatin


subject: CHEBI:3697


subject: PUBCHEM.COMPOUND:56971685

subject_name: Relebactam


subject: PUBCHEM.COMPOUND:56971685


subject: CHEBI:3207

subject_name: Budesonide

object_name: polyposis


subject: CHEBI:3207

object_name: chronic rhinosinusitis


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Childhood Synovial Sarcoma


subject: CHEBI:50847

object_name: Adult Synovial Sarcoma


subject: CHEBI:50847

object_name: synovial sarcoma


subject: CHEBI:50847

object_name: Childhood Neuroblastoma


subject: CHEBI:50847

object_name: neuroblastoma


subject: CHEBI:50847

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:50847

object_name: rhabdomyosarcoma


subject: CHEBI:50847

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:50847

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:50847

object_name: Ewing sarcoma


subject: CHEBI:50847

object_name: Osteosarcoma


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: Myelodysplasia


subject: CHEBI:197437

object_name: leukemia


subject: CHEBI:197437

object_name: childhood leukemia


subject: UMLS:C4048878

subject_name: MGCD 0103


subject: UMLS:C4048878


subject: UMLS:C4048878


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: opioid use


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:7852

subject_name: Oxycodone


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:74947

subject_name: Thalidomide

object_name: metastatic malignant neoplasm in the brain


subject: GTOPDB:9864

subject_name: tregalizumab

object_name: rheumatoid arthritis


subject: UNII:43D26MK176


subject: UMLS:C4519743


subject: CHEBI:4911

subject_name: Etoposide

object_name: adrenal carcinoma


subject: CHEBI:4911

object_name: adrenal cortex carcinoma


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:6954

subject_name: Mitotane


subject: CHEBI:6954


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol


subject: PUBCHEM.COMPOUND:3080587


subject: UNII:H81695M5OP

subject_name: nattokinase

object_name: abdominal obesity-metabolic syndrome


subject: UNII:H81695M5OP

object_name: metabolic syndrome X


subject: UNII:H81695M5OP

object_name: sleep disorder


subject: UMLS:C0131956


subject: UMLS:C0131956


subject: UMLS:C0131956


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Carcinoma breast stage IV


subject: UNII:1C6V77QF41

object_name: Estrogen Receptor Positive


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE


subject: PUBCHEM.COMPOUND:9848990

object_name: Opiate Overdose


subject: PUBCHEM.COMPOUND:9848990

object_name: Substance Use Disorders


subject: CHEBI:9654

subject_name: Trazodone

object_name: insomnia


subject: CHEBI:9654

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:9654

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Burn injury


subject: CHEBI:38290

object_name: Burn shock


subject: CHEBI:38290

object_name: Fluid and electrolyte imbalance


subject: CHEBI:38290

object_name: Partial thickness burn


subject: CHEBI:38290

object_name: Full thickness burn


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:4953

subject_name: Exemestane

object_name: prostate carcinoma


subject: CHEBI:4953

object_name: prostate cancer


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Under general anesthesia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:S82A18Y42P

subject_name: Etripamil

object_name: atrial fibrillation


subject: UNII:S82A18Y42P

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:S82A18Y42P

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:23359

subject_name: colchicine

object_name: Pseudogout


subject: CHEBI:6801

subject_name: Metformin

object_name: Alport syndrome


subject: CHEBI:23359


subject: CHEBI:23359


subject: CHEBI:23359


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: acute kidney failure


subject: MESH:D000077203

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: primary ovarian failure


subject: PUBCHEM.COMPOUND:134506

object_name: premature menopause


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: UNII:4521NR0J09

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL5095105

subject_name: LORUNDROSTAT

object_name: hypertension


subject: CHEMBL.COMPOUND:CHEMBL5095105

object_name: Hypertension, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5095105

object_name: obstructive sleep apnea syndrome


subject: DRUGBANK:DB18957

subject_name: Lorundrostat


subject: DRUGBANK:DB18957


subject: DRUGBANK:DB18957


subject: UMLS:C4706052

object_name: Crohn disease


subject: UMLS:C0696725

subject_name: Huang Lian preparation

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: binge eating


subject: CHEBI:16724

object_name: HIV infection


subject: CHEBI:30830

subject_name: sodium oxybate


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: inflammatory bowel disease


subject: CHEBI:41879

object_name: Postoperative Complications


subject: CHEBI:41879

object_name: Postoperative ileus


subject: UMLS:C5784956

subject_name: FGFR Inhibitor ET0111

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: prostate carcinoma


subject: CHEBI:144551

subject_name: Oxybutynin


subject: UNII:4DVS4AG4DF

subject_name: albinterferon alfa-2b

object_name: chronic hepatitis B virus infection


subject: UNII:4DVS4AG4DF

object_name: hepatitis B


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UNII:43K1W2T1M6


subject: UMLS:C2603873

subject_name: Zalbin


subject: UMLS:C2603873


subject: UNII:S9OX9692ZB

subject_name: galiximab

object_name: non-Hodgkin lymphoma


subject: UMLS:C1098262


subject: CHEBI:7773

subject_name: Ondansetron

object_name: intestinal motility disease


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Sepsis


subject: CHEBI:9150

object_name: Sepsis, CTCAE


subject: CHEBI:76842

object_name: Pitt-Hopkins syndrome


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:131389

subject_name: magnesium citrate


subject: CHEBI:131391


subject: CHEBI:74224

object_name: colorectal cancer


subject: CHEBI:74224

object_name: colorectal carcinoma


subject: CHEBI:74224

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:74224

object_name: rectal carcinoma


subject: CHEBI:74224

object_name: rectal cancer


subject: CHEBI:74224

object_name: Childhood Rectal Carcinoma


subject: CHEBI:74224

object_name: colon carcinoma


subject: CHEBI:74224

object_name: colon cancer


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: intracerebral hemorrhage


subject: CHEBI:231683

subject_name: Anakinra

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:231683

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:231683

object_name: High grade B-cell lymphoma refractory


subject: CHEBI:231683

object_name: High grade B-cell lymphoma recurrent


subject: CHEBI:231683

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: CHEBI:231683

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: CHEBI:231683

object_name: Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:231683

object_name: Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:231683

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:231683

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: atrial fibrillation


subject: CHEBI:25681

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:25681

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Recurrent ovarian cancer


subject: CHEBI:38940

object_name: ovarian clear cell adenocarcinoma


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: colorectal cancer


subject: MESH:C079198

object_name: colorectal carcinoma


subject: MESH:C079198

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL2108612

subject_name: IRATUMUMAB

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108612

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108612

object_name: pediatric lymphoma


subject: UMLS:C1327954

subject_name: iratumumab


subject: UMLS:C1327954


subject: UMLS:C1327954


subject: PR:000017503

subject_name: solute carrier family 53 member 1

object_name: type 2 diabetes mellitus


subject: PR:000006336

subject_name: L-xylulose reductase


subject: CHEBI:72296

subject_name: Apixaban

object_name: transient ischemic attack


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Critical Illness


subject: CHEBI:42797

object_name: Sleep Deprivation


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Surgical wound, healed


subject: CHEBI:91872

object_name: Vomiting, CTCAE


subject: CHEBI:91872

object_name: Vomiting


subject: CHEBI:91872

object_name: Nausea, CTCAE_5


subject: CHEBI:91872

object_name: Nausea


subject: CHEBI:91872

object_name: Nausea, CTCAE_3


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: malignant soft tissue neoplasm


subject: CHEBI:41879

object_name: sarcoma


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: CHEBI:73805


subject: CHEBI:73805


subject: CHEBI:73805


subject: CHEBI:73805


subject: CHEBI:73805


subject: CHEBI:73805


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C0728750

subject_name: Zinecard


subject: UMLS:C0728750


subject: UMLS:C0728750


subject: UMLS:C0728750


subject: UMLS:C0728750


subject: UMLS:C0728750


subject: UMLS:C0728750


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: primary biliary cholangitis


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: acoustic neuroma


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: parasitic infectious disease


subject: PUBCHEM.COMPOUND:6427057

object_name: bacterial infectious disease


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: PUBCHEM.COMPOUND:2269


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Childhood Breast Carcinoma


subject: UMLS:C4086546

object_name: breast carcinoma


subject: UMLS:C4086546

object_name: breast cancer


subject: CHEBI:93772

subject_name: Ispinesib

object_name: Blast Phase


subject: CHEBI:93772

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:93772

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:93772

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:93772

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:93772

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:93772

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:93772

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:93772

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:93772

object_name: acute undifferentiated leukemia


subject: CHEBI:93772

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:93772

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:93772

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:93772

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:93772

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:93772

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:93772

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:93772

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:93772

object_name: adult acute monocytic leukemia


subject: CHEBI:93772

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:93772

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:93772

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:93772

object_name: Adult Acute Promyelocytic Leukemia


subject: CHEBI:93772

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:93772

object_name: Adult Erythroleukemia


subject: CHEBI:93772

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:93772

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:93772

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:193615

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:193615

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:193615

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:62880

subject_name: Veliparib


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:45716

subject_name: Vorinostat

object_name: HIV infection


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Control of hip fracture risk


subject: CHEBI:119915

object_name: hip fracture


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:8884

subject_name: Rocuronium


subject: CHEBI:8884


subject: UMLS:C0148153

subject_name: Vaminolac

object_name: ulcerative colitis


subject: UMLS:C0148153

object_name: inflammatory bowel disease 1


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:25E79B5CTM

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: non-small cell lung carcinoma


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: myocardial infarction


subject: UNII:X85G7936GV

object_name: Myocardial Infarction, CTCAE


subject: UNII:X85G7936GV

object_name: Myocardial Infarction by ECG Finding


subject: UNII:DQA630RIE9

subject_name: Reteplase


subject: UNII:DQA630RIE9


subject: UNII:DQA630RIE9


subject: UMLS:C0106660


subject: UMLS:C0106660


subject: UMLS:C0106660


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: PR:000012825


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib

object_name: adult germ cell tumor


subject: PUBCHEM.COMPOUND:139350422

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:139350422

object_name: childhood germ cell tumor


subject: PUBCHEM.COMPOUND:139350422

object_name: Germ Cell Cancer


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: PUBCHEM.COMPOUND:2154

subject_name: Aminopterin

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:2154

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:2154

object_name: endometrial carcinoma


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Neuropathic spinal arthropathy


subject: CHEBI:74705

object_name: Intraoperative Hemorrhage


subject: CHEBI:74705

object_name: Degenerative lumbar spinal stenosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C3467937

subject_name: PSI 6130 Diisobutyrate

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:67036325

subject_name: Danoprevir


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Evidence of liver transplantation


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: PUBCHEM.COMPOUND:2269

object_name: Neonatal death


subject: PUBCHEM.COMPOUND:2269

object_name: neonatal sepsis


subject: PUBCHEM.COMPOUND:2269

object_name: Bacterial sepsis of newborn


subject: PUBCHEM.COMPOUND:2269

object_name: Maternal Death


subject: PUBCHEM.COMPOUND:2269

object_name: Sepsis during labor


subject: PUBCHEM.COMPOUND:2269

object_name: maternal infectious disease affecting fetus or newborn


subject: PUBCHEM.COMPOUND:2269

object_name: Puerperal sepsis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Community-Acquired Pneumonia


subject: UMLS:C2092279

subject_name: Sodium Chloride Liquid Injection


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: liver carcinoma


subject: CHEBI:6888

object_name: Immunosuppression


subject: CHEBI:6888

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:6888

object_name: Postoperative Complications


subject: CHEBI:9654

subject_name: Trazodone

object_name: sexual disorder


subject: CHEBI:9654

object_name: physiological sexual disorder


subject: UMLS:C5418061

object_name: plasma cell myeloma


subject: UMLS:C3896909

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C3896909

object_name: chronic myelomonocytic leukemia


subject: UMLS:C3896909

object_name: Myelodysplasia


subject: UMLS:C3896909

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3896909

object_name: acute myeloid leukemia


subject: MESH:C000728347

object_name: type 2 diabetes mellitus


subject: MESH:C000728347

object_name: Prediabetes


subject: MESH:C000728347

object_name: hypertriglyceridemia


subject: MESH:C000728347

object_name: Hypertriglyceridemia, CTCAE


subject: MESH:C000728347

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:C000728347

object_name: obesity


subject: MESH:C000728347

object_name: Obesity, CTCAE


subject: MESH:C000728347

object_name: Insulin resistance


subject: MESH:C000728347

object_name: disease


subject: UMLS:C5828997


subject: UMLS:C5828997


subject: UMLS:C5828997


subject: UMLS:C5828997


subject: UMLS:C5828997


subject: UMLS:C5828997


subject: UMLS:C5828997


subject: UMLS:C5828997


subject: UMLS:C5828997


subject: CHEBI:201756

subject_name: Clindamycin 2-Phosphate

object_name: bacterial vaginosis


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:9139

subject_name: Sildenafil

object_name: impotence


subject: CHEBI:9139

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:9139

object_name: Erectile dysfunction


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: neurofibromatosis 1


subject: CHEBI:9168

object_name: neurofibromatosis type 1


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: complete trisomy 21


subject: CHEBI:5118

object_name: Down syndrome


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Primary malignant neoplasm


subject: CHEBI:46195

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:46195

object_name: chronic leukemia


subject: CHEBI:46195

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:46195

object_name: non-Hodgkin lymphoma


subject: CHEBI:46195

object_name: Lymphoma, Large-Cell, Follicular


subject: CHEBI:46195

object_name: Myelodysplasia


subject: CHEBI:46195

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:46195

object_name: myoclonic dystonia 11


subject: CHEBI:46195

object_name: graft versus host disease


subject: CHEBI:46195

object_name: Hodgkin Disease


subject: CHEBI:46195

object_name: Liquid Tumor


subject: CHEBI:46195

object_name: leukemia


subject: CHEBI:46195

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:46195

object_name: childhood leukemia


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442

object_name: cancer


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: UMLS:C4305964

object_name: uveitis


subject: UMLS:C4305964

object_name: Uveitis, CTCAE


subject: UMLS:C5555761

subject_name: Carbon C 11 YJH08

object_name: Childhood Solid Neoplasm


subject: UMLS:C5555761

object_name: Adult Solid Neoplasm


subject: UMLS:C5555761

object_name: Solid Neoplasm


subject: UMLS:C5555761

object_name: metastatic prostate carcinoma


subject: UMLS:C5555761

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C5555761

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C5555761

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C5555761

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UMLS:C5555761

object_name: castration-resistant prostate carcinoma


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: unspecified adult solid tumor, protocol specific


subject: PR:000001379


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: Lesion of cervix


subject: UMLS:C1512511

object_name: dysplasia of cervix


subject: UMLS:C3529624

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: obstructive sleep apnea syndrome


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: pulmonary large cell neuroendocrine carcinoma


subject: UMLS:C3827082


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: chronic hepatitis B virus infection


subject: CHEBI:31536

object_name: hepatitis B


subject: CHEBI:173106

subject_name: ferroptocide


subject: CHEBI:173106


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: CHEBI:63589

subject_name: Etravirine


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Acute Pain


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: DRUGBANK:DB18168

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:1QMD83K4YN

subject_name: Danavorexton

object_name: sleep apnea


subject: UNII:1QMD83K4YN

object_name: Sleep Apnea, CTCAE


subject: CHEBI:91207

subject_name: Dideoxyadenosine

object_name: liver carcinoma


subject: CHEBI:91207

object_name: Klatskin Tumor


subject: CHEBI:28139

subject_name: bis(4-chlorophenyl)acetic acid


subject: CHEBI:28139


subject: UNII:441P620G3P

subject_name: Citarinostat

object_name: smoldering plasma cell myeloma


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UMLS:C3641624

subject_name: XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410


subject: DRUGBANK:DB17085

object_name: Parkinson disease


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Early Stage Breast Carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C2983741

subject_name: Fluorouracil Implant


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:41774

subject_name: Tamoxifen


subject: UMLS:C2713900

object_name: EXCESS LMW-DNA


subject: CHEBI:151315

subject_name: Heparin

object_name: Oral Mucositis


subject: CHEBI:151315

object_name: stomatitis


subject: CHEBI:151315

object_name: oral mucositis


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: UNII:QMS40680K6


subject: UNII:QMS40680K6


subject: CHEBI:233436

subject_name: Tolebrutinib

object_name: Multiple sclerosis relapse


subject: DRUGBANK:DB18715


subject: CHEBI:91398

subject_name: Tivantinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Opioid use, unspecified


subject: CHEBI:231614

subject_name: Nivolumab

object_name: B-cell neoplasm


subject: UMLS:C2346820


subject: CHEBI:52172

subject_name: Nilotinib

object_name: chronic leukemia


subject: PUBCHEM.COMPOUND:60918

subject_name: tegaserod

object_name: Constipation


subject: PUBCHEM.COMPOUND:60918

object_name: Constipation, CTCAE


subject: PUBCHEM.COMPOUND:60918

object_name: chronic disease


subject: PUBCHEM.COMPOUND:60918

object_name: Chronic Disease


subject: CHEBI:41423

subject_name: Celecoxib

object_name: chronic pain (diagnosis)


subject: CHEBI:41423

object_name: Chronic pain


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Anterior Cruciate Ligament Injuries


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:41423


subject: CHEBI:49575

subject_name: Diazepam


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:6129

subject_name: Ketorolac


subject: UMLS:C5444544

subject_name: black tea

object_name: gingivitis


subject: CHEBI:3892

subject_name: Corticotropin

object_name: rheumatoid arthritis


subject: UMLS:C5201181

subject_name: H.P. acthar gel


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:46081

subject_name: Fluconazole


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: coronary artery disorder


subject: UNII:X85G7936GV

object_name: coronary atherosclerosis


subject: CHEBI:229764

subject_name: Selinexor

object_name: adult lymphoma


subject: CHEBI:229764

object_name: lymphoma


subject: CHEBI:229764

object_name: pediatric lymphoma


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:90001

object_name: clear cell renal carcinoma


subject: CHEBI:90001

object_name: renal cell adenocarcinoma


subject: CHEBI:90001

object_name: renal cell carcinoma


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:63634

subject_name: Valdecoxib

object_name: Post-Operative Pain


subject: CHEBI:45783

subject_name: Imatinib

object_name: Neck Carcinoma


subject: CHEBI:45783

object_name: head and neck neoplasm


subject: CHEBI:45783

object_name: head and neck cancer


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Melasma


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: small cell lung carcinoma


subject: UMLS:C4086228

subject_name: Curcuminoid

object_name: acute kidney failure


subject: UMLS:C4086228

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C4086228

object_name: chronic kidney disease


subject: UMLS:C4086228

object_name: Contrast media toxicity


subject: CHEBI:177512

subject_name: Sagopilone

object_name: breast neoplasm


subject: CHEBI:39867

subject_name: Valproic acid

object_name: migraine


subject: CHEBI:39867

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C5447471

subject_name: CXCR2 Agonist MGTA-145

object_name: Myelodysplasia


subject: UMLS:C5447471

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C5447471

object_name: childhood myelodysplastic syndrome


subject: UMLS:C5447471

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5447471

object_name: acute myeloid leukemia


subject: UMLS:C5447471

object_name: acute lymphoblastic leukemia


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Ischemic stroke


subject: CHEBI:25681

object_name: transient ischemic attack


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: PUBCHEM.COMPOUND:9831414


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: CHEBI:80961

object_name: Recurrent Rectal Cancer


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:31348

subject_name: Capecitabine


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:5847

subject_name: Raltitrexed


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: UNII:O1GX33ON8R

subject_name: Alexomycin

object_name: Metastatic non-small cell lung cancer


subject: UniProtKB:Q2YLX6

subject_name: RL25_BRUA2 Large ribosomal subunit protein bL25 (sprot)


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:93775

subject_name: Amethopterin

object_name: psoriasis vulgaris


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: cutaneous leishmaniasis


subject: UNII:DA709Q5020

subject_name: zalutumumab

object_name: Neck Carcinoma


subject: UNII:DA709Q5020

object_name: head and neck cancer


subject: UMLS:C1831978


subject: UMLS:C1831978


subject: PUBCHEM.COMPOUND:9918734

subject_name: Lemuteporfin

object_name: acne


subject: UNII:EZ109VJ012


subject: CHEBI:9168

subject_name: Sirolimus

object_name: sickle cell disease


subject: CHEBI:91951

object_name: Ovarian cancer stage IV


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UMLS:C4053607

object_name: Her2-receptor negative breast cancer


subject: UMLS:C4053607


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: UMLS:C1456762

object_name: basal cell carcinoma


subject: UMLS:C1456762

object_name: skin basal cell carcinoma


subject: CHEBI:64816

object_name: cholangiocarcinoma


subject: CHEBI:91872


subject: UNII:S7RL72610R

subject_name: gossypol acetic acid

object_name: Small cell lung cancer extensive stage


subject: UNII:S7RL72610R

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:35450

subject_name: GOSSYPOL ACETIC ACID


subject: PUBCHEM.COMPOUND:35450


subject: PUBCHEM.COMPOUND:22327742

subject_name: Gosspyl acetate


subject: PUBCHEM.COMPOUND:22327742


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:51450

subject_name: Bosentan

object_name: Digital ulcer


subject: CHEBI:51450

object_name: systemic sclerosis


subject: UMLS:C4086017

subject_name: BTK Inhibitor

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: CHEBI:36796

subject_name: duloxetine

object_name: Chronic primary headache


subject: UMLS:C1521807

object_name: stage I adult soft tissue sarcoma


subject: UMLS:C1521807

object_name: Stage I Adult Soft Tissue Sarcoma AJCC v7


subject: UMLS:C1521807

object_name: Stage II Adult Soft Tissue Sarcoma AJCC v7


subject: UMLS:C1521807

object_name: stage II adult soft tissue sarcoma


subject: UMLS:C1521807

object_name: stage III adult soft tissue sarcoma


subject: UMLS:C1521807

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Renal Colic, CTCAE


subject: CHEBI:46195

object_name: renal colic


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:8249

subject_name: Piroxicam


subject: CHEBI:8249


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Surgical procedure finding


subject: MESH:C433370

subject_name: Traumeel S


subject: UMLS:C5782829

subject_name: ROPivacaine 0.2% injectable solution

object_name: lung neoplasm


subject: CHEBI:38940

subject_name: Sunitinib

object_name: gastric neoplasm


subject: UMLS:C1704263

subject_name: green tea extract

object_name: Diabetic peripheral neuropathy


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: UMLS:C5417955


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: Childhood Breast Carcinoma


subject: CHEBI:91368

object_name: breast carcinoma


subject: CHEBI:91368

object_name: breast cancer


subject: CHEBI:49140


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: UNII:TUK9QB44B0


subject: UMLS:C5392518


subject: UMLS:C3899043

subject_name: Gallium Ga 68-RGD


subject: CHEBI:35111

subject_name: calcium monohydroxide

object_name: exposure, dental pulp


subject: CHEBI:35150

subject_name: calcium hydroxide


subject: CHEBI:31341

subject_name: calcium dihydroxide


subject: MESH:C086631

subject_name: mineral trioxide aggregate


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: kidney disorder


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN

object_name: venous thromboembolism


subject: UNII:7UQ7X4Y489

object_name: thrombophilia due to thrombin defect


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Pleural mesothelioma malignant advanced


subject: UMLS:C3827082


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: chronic hepatitis B virus infection


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: hepatitis B


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Duchenne muscular dystrophy


subject: DRUGBANK:DB15656

subject_name: ChAdOx1 nCoV-19


subject: UMLS:C5383286


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: Advanced Prostate Adenocarcinoma


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage III Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide


subject: PUBCHEM.COMPOUND:121489720


subject: PUBCHEM.COMPOUND:121489720


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:26X6QU3JUB

subject_name: BIFIDOBACTERIUM LONGUM R0175

object_name: anxiety


subject: UNII:26X6QU3JUB

object_name: anxiety disorder


subject: UNII:26X6QU3JUB

object_name: Anxiety symptoms


subject: UNII:26X6QU3JUB

object_name: Anxiety, CTCAE 3.0


subject: UNII:26X6QU3JUB

object_name: Anxiety, CTCAE 5.0


subject: UNII:26X6QU3JUB

object_name: Depressed mood


subject: UNII:26X6QU3JUB

object_name: Cancer patients and suicide and depression


subject: UNII:26X6QU3JUB

object_name: Depressed - symptom


subject: UNII:26X6QU3JUB

object_name: Depression, CTCAE


subject: UNII:26X6QU3JUB

object_name: Stress-related problem


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: acute lymphoblastic leukemia


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: adult lymphoma


subject: UNII:KXG2PJ551I

object_name: lymphoma


subject: UNII:KXG2PJ551I

object_name: pediatric lymphoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: endocrine exophthalmos


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: EXCESS LMW-DNA


subject: UMLS:C1832035


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB16611

subject_name: Tick-borne encephalitis vaccine (whole virus, inactivated)

object_name: tick-borne encephalitis


subject: UMLS:C0593408

subject_name: Tick-borne encephalitis vaccine


subject: UMLS:C5397328

subject_name: Vaccine product containing only Tick-borne encephalitis virus antigen (medicinal product)


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Upper Respiratory Infections


subject: CHEBI:6456

object_name: respiratory tract infectious disorder


subject: CHEBI:6456

object_name: Recurrent upper respiratory tract infections


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C5960315

subject_name: EP4 Receptor Antagonist YY001

object_name: Upper limb spasticity


subject: CHEBI:9316

subject_name: Sufentanil

object_name: chronic pain (diagnosis)


subject: CHEBI:9316

object_name: Chronic pain


subject: UNII:S276568KOY

subject_name: Gadopiclenol

object_name: CNS disorder


subject: UNII:S276568KOY

object_name: Pediatric Disorder


subject: UMLS:C5555141

object_name: large B-cell lymphoma


subject: UMLS:C4552073

subject_name: Calcium Aluminosilicate Anti-Diarrheal

object_name: diarrhea


subject: UMLS:C4552073

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C4552073

object_name: Diarrhea, CTCAE


subject: UMLS:C4552073

object_name: cancer


subject: UMLS:C4552073

object_name: neoplasm


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: Adult Solid Neoplasm


subject: UMLS:C4331912


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: plasma cell myeloma


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Bladder cancer recurrent


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: choroidal melanoma


subject: UNII:ZL1R02VT79

object_name: uveal melanoma


subject: UNII:ZL1R02VT79

object_name: malignant choroid melanoma


subject: UNII:ZL1R02VT79

object_name: Disorder of retina caused by radiation


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: coronary atherosclerosis


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Relapse multiple myeloma


subject: CHEBI:52717

object_name: Plasma cell myeloma recurrent


subject: CHEBI:67272

subject_name: Perifosine


subject: CHEBI:67272


subject: CHEBI:67272


subject: UNII:YSL2GUT2Q8

subject_name: RILVEGOSTOMIG

object_name: Childhood Solid Neoplasm


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8

object_name: Solid Neoplasm


subject: UMLS:C5706461

subject_name: Rilvegostomig


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: CHEMBL.COMPOUND:CHEMBL5314771

subject_name: SABESTOMIG


subject: CHEMBL.COMPOUND:CHEMBL5314771


subject: CHEMBL.COMPOUND:CHEMBL5314771


subject: UMLS:C5855296

subject_name: Sabestomig


subject: UMLS:C5855296


subject: UMLS:C5855296


subject: CHEMBL.COMPOUND:CHEMBL5095362

subject_name: VOLRUSTOMIG


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: UMLS:C5417881

subject_name: Volrustomig


subject: UMLS:C5417881


subject: UMLS:C5417881


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: autoimmune encephalitis


subject: CHEBI:135956

subject_name: Vernakalant

object_name: atrial fibrillation


subject: CHEBI:135956

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:135956

object_name: Atrial Fibrillation, CTCAE


subject: GTOPDB:12989

subject_name: toripalimab

object_name: nasopharyngeal carcinoma


subject: GTOPDB:12989

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4719126

subject_name: cycloSPORINE ophthalmic 0.1% ophthalmic emulsion

object_name: Ocular surface disease


subject: UMLS:C4719126

object_name: Ocular Surface Disease, CTCAE


subject: UMLS:C4719126

object_name: Inflammatory abnormality of the eye


subject: UNII:P76B05O5V6

subject_name: Relugolix

object_name: prostate carcinoma


subject: UNII:P76B05O5V6

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:9834332

subject_name: Brivaracetam

object_name: epilepsy


subject: UMLS:C0162758

subject_name: Serotonin Uptake Inhibitors

object_name: stroke disorder


subject: UMLS:C0162758

object_name: cerebrovascular disorder


subject: UMLS:C0162758

object_name: Stroke (heart beat)


subject: UMLS:C0162758

object_name: Stroke, CTCAE


subject: GTOPDB:6803

subject_name: dalteparin

object_name: cancer


subject: GTOPDB:6803

object_name: neoplasm


subject: UNII:V0Q46LFE6F

object_name: KRAS mutation-related tumors


subject: UNII:V0Q46LFE6F

object_name: pancreatic neoplasm


subject: UNII:V0Q46LFE6F

object_name: exocrine pancreatic carcinoma


subject: UNII:V0Q46LFE6F

object_name: malignant pancreatic neoplasm


subject: UNII:V0Q46LFE6F

object_name: colorectal cancer


subject: UNII:V0Q46LFE6F

object_name: colorectal carcinoma


subject: UNII:V0Q46LFE6F

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:V0Q46LFE6F

object_name: non-small cell lung carcinoma


subject: UMLS:C4744415

subject_name: PTPN11 Inhibitor RMC-4630


subject: UMLS:C4744415


subject: UMLS:C4744415


subject: UMLS:C4744415


subject: UMLS:C4744415


subject: UMLS:C4744415


subject: UMLS:C4744415


subject: UMLS:C4744415


subject: UNII:T12B44A1OE

subject_name: Acoramidis

object_name: polyneuropathy


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Inclusion Body Myopathy, Sporadic


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: spinal cord injury


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:90227

subject_name: Selumetinib

object_name: neurofibromatosis 1


subject: CHEBI:90227

object_name: neurofibromatosis type 1


subject: CHEBI:90227

object_name: plexiform neurofibroma


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: follicular lymphoma


subject: UNII:4Z63YK6E0E

object_name: diffuse large B-cell lymphoma


subject: UNII:4Z63YK6E0E

object_name: mantle cell lymphoma


subject: UMLS:C3827070


subject: UMLS:C3827070


subject: UMLS:C3827070


subject: UMLS:C3827070

object_name: ovarian serous adenocarcinoma


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: leukemia


subject: PUBCHEM.COMPOUND:23724878

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:23724878

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:23724878

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:23724878

object_name: Lymphoblastic leukemia in children


subject: PUBCHEM.COMPOUND:11094963


subject: PUBCHEM.COMPOUND:11094963


subject: PUBCHEM.COMPOUND:11094963


subject: PUBCHEM.COMPOUND:11094963


subject: PUBCHEM.COMPOUND:11094963


subject: CHEBI:87211

subject_name: fluoroquinolone antibiotic


subject: CHEBI:87211


subject: CHEBI:87211


subject: CHEBI:87211


subject: CHEBI:87211


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Persistent asthma


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: pancreatic neoplasm


subject: CHEBI:141969

object_name: exocrine pancreatic carcinoma


subject: CHEBI:141969

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:72990174

object_name: renal cell carcinoma


subject: UMLS:C1706674


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Iron deficiency


subject: PUBCHEM.COMPOUND:92043599

object_name: iron deficiency anemia


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: anemia


subject: CHEBI:28911

object_name: Anemia, CTCAE


subject: CHEBI:28911


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: UMLS:C2348994

object_name: prostate carcinoma


subject: UMLS:C2348994

object_name: prostate cancer


subject: UMLS:C2348994

object_name: pleomorphic adenoma


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: Childhood Breast Carcinoma


subject: UNII:CJN36EQM0H

object_name: breast carcinoma


subject: UNII:CJN36EQM0H

object_name: breast cancer


subject: UMLS:C2742210

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2742210

object_name: clear cell renal carcinoma


subject: CHEBI:184662

object_name: rheumatoid arthritis


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: Primary malignant neoplasm


subject: CHEBI:64321

object_name: cancer


subject: CHEBI:64321

object_name: childhood malignant neoplasm


subject: CHEBI:64321

object_name: Malignant obstetric neoplasm


subject: CHEBI:194146

object_name: Neck Carcinoma


subject: CHEBI:194146

object_name: head and neck neoplasm


subject: CHEBI:194146

object_name: head and neck cancer


subject: CHEBI:125354

subject_name: Plerixafor

object_name: sickle cell disease


subject: CHEBI:50730

subject_name: Montelukast

object_name: Anterior Cruciate Ligament Injuries


subject: CHEBI:50730

object_name: Finding of tear meniscus (eye)


subject: CHEBI:50730

object_name: Torn meniscus


subject: CHEBI:50730

object_name: Post traumatic osteoarthritis


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: Acute Ischemic Stroke


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604

object_name: Ischemic stroke


subject: CHEBI:6520

subject_name: Lomustine

object_name: glioblastoma


subject: CHEBI:6520

object_name: Childhood Glioblastoma


subject: CHEBI:6520

object_name: adult glioblastoma


subject: UMLS:C5447588

subject_name: Anti-MUC1/EGFR Bispecific Antibody Drug Conjugate M1231

object_name: non-small cell lung carcinoma


subject: UMLS:C5447588

object_name: carcinoma of esophagus


subject: UMLS:C5447588

object_name: esophageal cancer


subject: UMLS:C5447588

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5447588

object_name: neoplasm of esophagus


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Femoroacetabular impingement


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:82977

subject_name: Daclatasvir

object_name: end stage renal failure


subject: CHEBI:82977

object_name: Chronic uremia


subject: CHEBI:82977

object_name: kidney failure


subject: UMLS:C5400891


subject: UMLS:C5400891


subject: UMLS:C5400891


subject: PUBCHEM.COMPOUND:66811198

subject_name: SIMEPREVIR


subject: PUBCHEM.COMPOUND:66811198


subject: PUBCHEM.COMPOUND:66811198


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: malignant pleural mesothelioma


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:63918

subject_name: Artesunate

object_name: parasitic infectious disease


subject: CHEBI:63609

subject_name: mefloquine

object_name: malaria


subject: CHEBI:63609


subject: CHEBI:34911

subject_name: Permethrin


subject: CHEBI:34911


subject: CHEBI:8405

subject_name: Primaquine


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Burn injury


subject: CHEBI:94518

object_name: Burn, CTCAE


subject: CHEBI:133021

subject_name: Venetoclax

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C5139693

subject_name: Pegbelfermin


subject: UMLS:C5139942


subject: UMLS:C2606533

subject_name: Hemospan

object_name: hypotension


subject: UMLS:C2606533

object_name: Hypotension, CTCAE


subject: UMLS:C2606533

object_name: ischemia


subject: CHEBI:142708

object_name: Abdominal Infection


subject: CHEBI:142708

object_name: Soft Tissue Infection


subject: CHEBI:142708

object_name: skin disorder caused by infection


subject: CHEBI:142708

object_name: skin infection


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:149836


subject: CHEBI:149836


subject: CHEBI:149836


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: Chronic hepatitis C genotype 1


subject: UNII:Q46947FE7K

object_name: Treatment naive


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:68595

subject_name: Telaprevir


subject: CHEBI:68595


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Disseminated Malignant Neoplasm


subject: GTOPDB:4942

object_name: Embolism, Tumor


subject: GTOPDB:4942

object_name: Neoplasm Metastasis


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: endogenous depression


subject: CHEBI:135925

object_name: major depressive disorder


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: small cell lung carcinoma


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:6775

subject_name: Mesalazine

object_name: colorectal cancer


subject: CHEBI:6775

object_name: colorectal carcinoma


subject: CHEBI:6775

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:184910

subject_name: Rotigotine

object_name: Parkinson disease


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: Fractures, Ununited


subject: CHEBI:27812

object_name: Non-Ossifying Fibroma


subject: UMLS:C4310418

object_name: type 2 diabetes mellitus


subject: UMLS:C5446554

object_name: Childhood Solid Neoplasm


subject: UMLS:C5446554

object_name: Adult Solid Neoplasm


subject: UMLS:C5446554

object_name: Solid Neoplasm


subject: UMLS:C5446554

object_name: liver carcinoma


subject: UMLS:C5446554

object_name: endometrial cancer


subject: UMLS:C5446554

object_name: uterine corpus cancer


subject: UMLS:C5446554

object_name: endometrial carcinoma


subject: UMLS:C5446554


subject: UMLS:C5446554


subject: UMLS:C5446554


subject: UMLS:C5446554

object_name: ovarian cancer


subject: UMLS:C5446554

object_name: ovarian neoplasm


subject: UMLS:C5446554

object_name: ovarian carcinoma


subject: UMLS:C5446554

object_name: non-small cell lung carcinoma


subject: UNII:Y8KTZ6Y35U

subject_name: PEGCRISANTASPASE

object_name: acute lymphoblastic leukemia


subject: UNII:Y8KTZ6Y35U

object_name: lymphoblastic lymphoma


subject: UNII:Y8KTZ6Y35U

object_name: Adult Lymphoblastic Lymphoma


subject: UNII:Y8KTZ6Y35U

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C3640058

subject_name: Asparec


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: UMLS:C3640058


subject: CHEBI:8988

object_name: Small cell lung cancer recurrent


subject: CHEBI:80630

subject_name: Irinotecan


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Hypothyroidism caused by radiation


subject: CHEBI:18332

subject_name: Levothyroxine


subject: UMLS:C5554937

subject_name: PARP 1/2 Inhibitor SC10914

object_name: Carcinoma breast stage IV


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: brain neoplasm


subject: CHEBI:17549

object_name: Recurrent Brain Neoplasm


subject: CHEBI:17549

object_name: brain cancer


subject: CHEBI:17549

object_name: primary brain neoplasm


subject: CHEBI:17549

object_name: benign neoplasm of brain


subject: CHEBI:17549

object_name: glioblastoma


subject: CHEBI:17549

object_name: Childhood Glioblastoma


subject: CHEBI:17549

object_name: adult glioblastoma


subject: UMLS:C3274911

subject_name: Gliolan

object_name: glioma


subject: UMLS:C3274911


subject: UMLS:C3274911


subject: UMLS:C3274911


subject: UMLS:C3274911


subject: UMLS:C3274911


subject: UMLS:C3274911


subject: UMLS:C3274911


subject: UMLS:C3274911


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: neoplasm


subject: CHEBI:91400

subject_name: Afatinib


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: non-small cell lung carcinoma


subject: UNII:73096E137E


subject: CHEBI:229648

subject_name: Flotufolastat F-18

object_name: prostate carcinoma


subject: CHEBI:229648

object_name: prostate cancer


subject: CHEBI:30427

subject_name: gallane


subject: CHEBI:30427


subject: CHEMBL.COMPOUND:CHEMBL1201200

subject_name: GALLIUM


subject: CHEMBL.COMPOUND:CHEMBL1201200


subject: CHEBI:49631

subject_name: gallium atom


subject: CHEBI:49631


subject: UNII:98B30EPP5S


subject: UNII:98B30EPP5S


subject: UNII:82VH67YON8

subject_name: PIFLUFOLASTAT


subject: UNII:82VH67YON8


subject: CHEBI:36939

subject_name: Fluorine F-18


subject: CHEBI:36939


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: multicentric Castleman disease


subject: UNII:AG9MHG098Z

object_name: idiopathic multicentric Castleman disease


subject: CHEBI:6504

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: cervical polyp


subject: PUBCHEM.COMPOUND:14907381

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:14907381

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: endometrium neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: gallbladder neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: ovarian neoplasm


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410

object_name: liver carcinoma


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V

object_name: head and neck squamous cell carcinoma


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V

object_name: neoplasm of esophagus


subject: UNII:2S9ZZM9Q9V

object_name: gastric neoplasm


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: GTOPDB:11129

object_name: viral pneumonia


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA


subject: UMLS:C5443462


subject: UMLS:C5543892


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: melanoma


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Regional anesthesia morbidity


subject: CHEBI:6149

object_name: cholecystolithiasis


subject: CHEBI:6149

object_name: gallstones


subject: CHEBI:6149

object_name: cholelithiasis


subject: CHEMBL.COMPOUND:CHEMBL4298001

subject_name: CETRELIMAB

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C4329336


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:5466794

object_name: kidney neoplasm


subject: PUBCHEM.COMPOUND:5466794

object_name: kidney cancer


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: hepatitis B


subject: CHEBI:134504


subject: PUBCHEM.COMPOUND:2269

object_name: bronchiolitis obliterans syndrome


subject: PUBCHEM.COMPOUND:2269


subject: PUBCHEM.COMPOUND:2269

object_name: chronic graft versus host disease


subject: PUBCHEM.COMPOUND:2269

object_name: lung disorder


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: UNII:834YJF89WO

subject_name: Belumosudil


subject: UNII:834YJF89WO


subject: UNII:834YJF89WO


subject: UNII:834YJF89WO


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:5134


subject: CHEBI:5134


subject: CHEBI:5134


subject: CHEBI:50730

subject_name: Montelukast


subject: CHEBI:50730


subject: CHEBI:50730


subject: CHEBI:50730


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UMLS:C0302206

subject_name: Iron salt

object_name: Iron deficiency anemia of pregnancy


subject: CHEBI:31607

subject_name: Ferrous fumarate


subject: CHEBI:33330

subject_name: scandium atom

object_name: interstitial lung disease


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: CHEBI:73611

subject_name: Met-Gly


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C1134588


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: dyslexia


subject: PUBCHEM.COMPOUND:18140

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:18140

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:18140

object_name: breast cancer


subject: CHEBI:4868

subject_name: Estramustine


subject: CHEBI:4868


subject: CHEBI:4868


subject: UNII:M671F9NLEA

subject_name: CANRENOATE POTASSIUM

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:50156

subject_name: Canrenoic acid


subject: UNII:94W010PZ1Z

object_name: Heartburn


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: malaria


subject: UMLS:C0041044


subject: CHEBI:194539

subject_name: tennessine atom


subject: CHEBI:169954

subject_name: Thr-Ser


subject: CHEBI:133246

subject_name: Ligustrazine


subject: CHEBI:45394

subject_name: TMP


subject: CHEBI:46324

subject_name: trimethyl phosphate


subject: CHEBI:9533

subject_name: thiamine(1+) monophosphate


subject: CHEBI:17013

subject_name: dTMP


subject: CHEBI:63528


subject: CHEBI:45924

subject_name: Trimethoprim


subject: UMLS:C0384479

subject_name: epithelial membrane protein-1


subject: PR:000007062

subject_name: epithelial membrane protein 1


subject: UniProtKB:P36590

subject_name: KTHY_SCHPO Thymidylate kinase (sprot)


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:DPT0O3T46P

object_name: Refractory Hepatocellular Carcinoma


subject: UNII:DPT0O3T46P

object_name: BCLC Stage B Hepatocellular Carcinoma


subject: UNII:DPT0O3T46P

object_name: BCLC Stage C Hepatocellular Carcinoma


subject: CHEBI:4875

subject_name: Etanercept

object_name: Langerhans cell histiocytosis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: coronary microvascular disorder


subject: CHEBI:46245

object_name: Increased reactive oxygen species production


subject: CHEBI:46245

object_name: Inflammation


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: Cytomegalovirus viremia


subject: CHEBI:63635

object_name: EBV viraemia


subject: CHEBI:232592

object_name: malignant glomus tumor


subject: CHEBI:232592

object_name: adrenal cortex carcinoma


subject: CHEBI:232592

object_name: adenoid cystic carcinoma


subject: CHEBI:232592

object_name: liver carcinoma


subject: CHEBI:232592

object_name: colorectal cancer


subject: CHEBI:232592

object_name: colorectal carcinoma


subject: CHEBI:232592

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:232592

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:232592

object_name: non-Hodgkin lymphoma


subject: CHEBI:232592

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:232592

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:232592

object_name: Childhood Breast Carcinoma


subject: CHEBI:232592

object_name: breast carcinoma


subject: CHEBI:232592

object_name: breast cancer


subject: CHEBI:232592

object_name: pediatric osteosarcoma


subject: CHEBI:232592

object_name: Osteosarcoma


subject: CHEBI:232592

object_name: Pre T-ALL


subject: CHEBI:232592

object_name: adult T-cell leukemia/lymphoma


subject: CHEBI:232592

object_name: precursor T-cell acute lymphoblastic leukemia


subject: UMLS:C3887632

subject_name: human colostrum

object_name: ankyloglossia


subject: UMLS:C0939935

subject_name: Colostrum Preparation


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Therapy Object (animal model)


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6121

subject_name: Ketamine


subject: UMLS:C5848358

object_name: hemophilia A


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UNII:XZ73ATU8W7

subject_name: Cdk4 inhibitor


subject: UNII:XZ73ATU8W7


subject: UNII:XZ73ATU8W7


subject: UNII:XZ73ATU8W7


subject: UMLS:C5781372

subject_name: Cyclin-Dependent Kinase 4 Inhibitor


subject: UMLS:C5781372


subject: UMLS:C5781372


subject: UMLS:C5781372


subject: CHEBI:50792

subject_name: estrogen receptor antagonist


subject: CHEBI:50792


subject: CHEBI:50792


subject: CHEBI:50792


subject: UMLS:C2267020

subject_name: Estrogen Receptor Inhibitor [EPC]


subject: UMLS:C2267020


subject: UMLS:C2267020


subject: UMLS:C2267020


subject: UMLS:C3850168

subject_name: Estrogen Receptor Antagonists


subject: UMLS:C3850168


subject: UMLS:C3850168


subject: UMLS:C3850168


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: disorder of orbital region


subject: UNII:ZL1R02VT79

object_name: eye disorder


subject: UMLS:C2981231

subject_name: fulranumab

object_name: osteoarthritis


subject: UMLS:C2981231

object_name: osteoarthritis, knee


subject: UMLS:C2981231

object_name: osteoarthritis, hip


subject: UMLS:C2981231

object_name: Arthralgia


subject: UMLS:C2981231

object_name: Joint Pain, CTCAE


subject: UMLS:C2981231

object_name: Arthralgia, CTCAE


subject: UNII:51FM2R4Y24

subject_name: ANGIOTENSIN-CONVERTING ENZYME

object_name: proteinuria


subject: UNII:51FM2R4Y24

object_name: Proteinuria of undiagnosed cause


subject: UNII:51FM2R4Y24

object_name: Proteinuria, CTCAE 3.0


subject: UNII:51FM2R4Y24

object_name: Proteinuria, CTCAE 5.0


subject: UNII:51FM2R4Y24

object_name: diabetic kidney disease


subject: UMLS:C1999216

subject_name: Inhibitor


subject: UMLS:C1999216


subject: UMLS:C1999216


subject: UMLS:C1999216


subject: UMLS:C1999216


subject: UMLS:C0529330

subject_name: Receptor, Angiotensin, Type 1


subject: UMLS:C0529330


subject: UMLS:C0529330


subject: UMLS:C0529330


subject: UMLS:C0529330


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: CHEBI:27363

subject_name: Zinc

object_name: diarrhea


subject: CHEBI:27363

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:27363

object_name: Diarrhea, CTCAE


subject: MESH:D056692

subject_name: Prebiotics


subject: MESH:D056692


subject: MESH:D056692


subject: UNII:BPR0F3X56H

subject_name: Lancovutide

object_name: cystic fibrosis


subject: UMLS:C1311572


subject: UMLS:C0733521

subject_name: Ara-C

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0733521

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0733521

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:63609

subject_name: mefloquine

object_name: Pregnant


subject: CHEBI:63609

object_name: HIV infection


subject: UNII:9T210MMZ3F

subject_name: Blarcamesine

object_name: Alzheimer disease


subject: UMLS:C5700351


subject: UNII:ZNC37E4KAK

subject_name: ELRITERCEPT

object_name: Myelodysplasia


subject: UMLS:C5417971

subject_name: Elritercept


subject: PUBCHEM.COMPOUND:53427024

subject_name: Arimoclomol

object_name: inclusion body myositis


subject: UNII:39HBQ4A67L

subject_name: Mobocertinib

object_name: non-small cell lung carcinoma


subject: UMLS:C3886322

object_name: trigeminal neuralgia


subject: UNII:WB8FT61183

object_name: heart failure


subject: UNII:WB8FT61183

object_name: Heart Failure, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: chronic myelomonocytic leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367

object_name: graft versus host disease


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339

object_name: myeloproliferative neoplasm


subject: CHEBI:82339

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:82339

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:82339

object_name: childhood myelodysplastic syndrome


subject: CHEBI:82339

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:82339

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UNII:9RV78Q2002

subject_name: Vedolizumab


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002

object_name: acute lymphoblastic leukemia


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002

object_name: acute myeloid leukemia


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513

object_name: Myelodysplasia


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UNII:26RU378B9V


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: peptic esophagitis


subject: CHEBI:6375

object_name: Gastro-esophageal reflux disease with esophagitis


subject: PUBCHEM.COMPOUND:153563259

subject_name: FOSIGOTIFATOR

object_name: leukoencephalopathy with vanishing white matter 5


subject: PUBCHEM.COMPOUND:153563259

object_name: leukoencephalopathy with vanishing white matter


subject: PUBCHEM.COMPOUND:153563259

object_name: leukoencephalopathy with vanishing white matter 1


subject: DRUGBANK:DB19409

subject_name: Fosigotifator


subject: DRUGBANK:DB19409


subject: DRUGBANK:DB19409


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Intrabony periodontal defect


subject: CHEBI:39548

object_name: Chronic periaortitis


subject: UMLS:C0967624

object_name: small cell lung carcinoma


subject: CHEBI:79040

subject_name: umeclidinium bromide

object_name: COPD, severe early onset


subject: CHEBI:79040

object_name: chronic obstructive pulmonary disease


subject: UNII:GE2T1418SV

subject_name: Umeclidinium


subject: UNII:GE2T1418SV


subject: UMLS:C2987383

object_name: Advanced cancer


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:75998

subject_name: Trametinib


subject: UMLS:C3661302

subject_name: Infanrix hexa

object_name: streptococcal infection


subject: UMLS:C2986399

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C2986399

object_name: progesterone-receptor positive breast cancer


subject: UMLS:C2986399

object_name: Breast cancer recurrent


subject: UMLS:C2986399

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C2986399

object_name: Carcinoma breast stage IV


subject: UMLS:C2986399

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2986399

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2986399

object_name: Her2-receptor negative breast cancer


subject: UMLS:C2986399

object_name: invasive ductal breast carcinoma


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Metastatic Uveal Melanoma


subject: UMLS:C4053601


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: heart failure


subject: CHEBI:78870

object_name: Heart Failure, CTCAE


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Advanced lung cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UMLS:C5238987


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: Cognitive impairment


subject: CHEBI:4696

object_name: Effects of radiation


subject: CHEBI:145499

subject_name: Donepezil


subject: CHEBI:145499


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Helicobacter pylori infection


subject: CHEBI:77260

subject_name: Omeprazole


subject: PUBCHEM.COMPOUND:118987284

subject_name: Nexium


subject: CHEBI:7772

subject_name: omeprazole


subject: UMLS:C0591742

subject_name: Losec


subject: CHEBI:7915

subject_name: Pantoprazole


subject: PUBCHEM.COMPOUND:24840146

subject_name: BUTORPHANOL TARTRATE

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:24840146

object_name: Consent Type - Hysterectomy


subject: CHEBI:3242

subject_name: butorphanol


subject: CHEBI:3242


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal


subject: PUBCHEM.COMPOUND:9971980


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:32250


subject: CHEBI:75722

subject_name: Tramadol


subject: PUBCHEM.COMPOUND:156963740

subject_name: Dasiglucagon

object_name: familial hyperinsulinism


subject: PUBCHEM.COMPOUND:156963740

object_name: congenital isolated hyperinsulinism


subject: PUBCHEM.COMPOUND:131674970

subject_name: CEFTRIAXONE SODIUM

object_name: gonorrhea


subject: CHEBI:3514

subject_name: Ceftriaxone disodium salt hemiheptahydrate


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: DRUGBANK:DB14744

subject_name: Spirulina platensis

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB14744

object_name: obesity


subject: DRUGBANK:DB14744

object_name: Obesity, CTCAE


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Miscarriage


subject: CHEBI:50692

object_name: spontaneous abortion


subject: CHEBI:50692

object_name: Blighted ovum


subject: CHEBI:50692

object_name: Fetal Death


subject: CHEBI:63610

subject_name: Misoprostol


subject: CHEBI:63610


subject: CHEBI:63610


subject: CHEBI:63610


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: pseudohypoparathyroidism


subject: UNII:C137DTR5RG

object_name: Parathyroid Hormone Resistance


subject: UNII:C137DTR5RG

object_name: pseudohypoparathyroidism type 1A


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:28177


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:17061

object_name: Oral Complication


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:48538

subject_name: Apomorphine

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:166822065

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:166822065

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:166822065

object_name: breast cancer


subject: PUBCHEM.COMPOUND:166822065

object_name: PIK3CA Gene Mutation


subject: PUBCHEM.COMPOUND:166822065

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:166822065

object_name: Advanced breast cancer


subject: PUBCHEM.COMPOUND:166822065

object_name: Hormone receptor positive tumor


subject: PUBCHEM.COMPOUND:166822065

object_name: Her2-receptor negative breast cancer


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751


subject: DRUGBANK:DB16751